Mereo BioPharma Group plc (MREO)
NASDAQ·Healthcare·Biotechnology
$0.28
+15.04%
Mkt Cap $62.52M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$0.83
Range $0.50 – $1.00
Implied Upside
+197.7%
Consensus $0.83 vs current $0.28
NASDAQ·Healthcare·Biotechnology
$0.28
+15.04%
Mkt Cap $62.52M
No recent rating data.
Price Target (10 analysts)
$0.83
Range $0.50 – $1.00
+197.7%
Consensus $0.83 vs current $0.28